Bryan Smith, associate professor of biomedical engineering at MSU, and a team of scientists created a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.
The results, published in the current issue of Nature Nanotechnology, showcases the nanoparticle that homes in on atherosclerotic plaque due to its high selectivity to a particular immune cell type – monocytes and macrophages. Once inside the macrophages in those plaques, it delivers a drug agent that stimulates the cell to engulf and eat cellular debris. Basically, it removes the diseased/dead cells in the plaque core. By reinvigorating the macrophages, plaque size is reduced and stabilized.
Smith said that future clinical trials on the nanoparticle are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of the nanodrug.
Smith’s studies focus on intercepting the signaling of the receptors in the macrophages and sending a message via small molecules using nano-immunotherapeutic platforms. Previous studies have acted on the surface of the cells, but this new approach works intracellularly and has been effective in stimulating macrophages.
“We found we could stimulate the macrophages to selectively eat dead and dying cells – these inflammatory cells are precursor cells to atherosclerosis – that are part of the cause of heart attacks,” Smith said. “We could deliver a small molecule inside the macrophages to tell them to begin eating again.”
This approach also has applications beyond atherosclerosis, he added.
“We were able to marry a groundbreaking finding in atherosclerosis by our collaborators with the state-of-the-art selectivity and delivery capabilities of our advanced nanomaterial platform. We demonstrated the nanomaterials were able to selectively seek out and deliver a message to the very cells needed,” Smith said. “It gives a particular energy to our future work, which will include clinical translation of these nanomaterials using large animal models and human tissue tests. We believe it is better than previous methods.”
Smith has filed a provisional patent and will begin marketing it later this year.
A link to the original paper: https://www.nature.com/articles/s41565-019-0619-3
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Trojan Horse nanoparticle
- Nonviral Vectors for the Delivery of Small Interfering RNAs to the CNSon May 1, 2020 at 5:00 pm
They are not effective for gene delivery to the brain when administered intravenously, although 'Trojan horse' liposomes can be an exception. These nanoparticles have a better transfection ...
- Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapyon April 29, 2020 at 5:00 pm
Cancer immunotherapy, with an aim to enhance host immune responses, has been recognized as a promising therapeutic treatment for cancer. A diversity of immunomodulatory agents, including tumor ...
- Nanobiotechnology-Based Strategies for Crossing the Blood–Brain Barrieron April 29, 2020 at 5:00 pm
The blood–brain barrier (BBB ... based strategies for crossing the BBB include NPs for enhancing monoclonal antibody delivery across the BBB by the Trojan horse approach, use of peptide ...
- The STEM Awards 2020 Healthcare Challenge winneron April 24, 2020 at 3:15 am
Michele’s two-pronged approach is designed to trick the cancer, much like a Trojan Horse. First ... cancer cells and release heat-sensitive nanoparticles which, when activated, would heat ...
- Biogenic Metallic Nanoparticles. A Nanometric Trojan Horse Approachon May 22, 2019 at 7:19 pm
Pathogenic bacteria and human cells—both cancerous and healthy ones—were used for the synthesis of metallic nanoparticles. Bacteria and cells are cultured in the presence of metallic salts under ...
Go deeper with Google Headlines on:
Trojan Horse nanoparticle
Go deeper with Bing News on:
- Angina Pectoris: Epidemiology Forecast to 2028on May 8, 2020 at 11:07 am
Reportlinker.com announces the release of the report "Angina Pectoris: Epidemiology Forecast to 2028" - The reduced blood flow occurs when arteries that carry blood to the heart become narrowed and ...
- Blood vessels in obese teens age prematurely, study sayson May 8, 2020 at 12:15 am
Obesity, type 2 diabetes or high blood pressure increase teens' risk of premature blood vessel aging, a new study finds.
- Blood Vessels of Obese Teens Age Prematurelyon May 7, 2020 at 11:02 am
"What surprised our team the most was that participants with higher systolic blood pressure compared to their peers in the study had a very similar risk as those with obesity or t ...
- Optical imaging of tissue mechanics via laser speckle rheologyon May 7, 2020 at 6:48 am
A majority of disease conditions from cancer and atherosclerosis to neurodegenerative and orthopedic disorders are accompanied by changes in tissue stiffness. Clinical medicine has long relied on ...
- Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathyon May 7, 2020 at 2:11 am
Structural changes to the left ventricle are characteristic of dilated cardiomyopathy (DCM), a disease for which many rare genetic variants are known. Here, Pirruccello et al. report GWAS of seven ...